Johnson & Johnson (JNJ) Cash Flow Statement

The wide quarterly swings in OCF/NI, from 0.38 to 1.78, appear driven by working capital timing, particularly large swings in WC Chg (e.g., -$12.7B in 2025Q4 vs +$15.9B in 2025Q3). This suggests that reported net income is not consistently backed by cash generation in the same quarter, but the cumulative effect over the period may be more stable. Investors should monitor whether these swings reflect seasonal patterns or structural changes in cash collection.

The FCF margin in 2026Q2 is 13.4%, up from 6.1% in the prior quarter, but still below the 22.3% and 34.9% recorded in 2025Q4 and Q3, respectively. This volatility appears tied to working capital swings and acquisition outflows, as seen in the -$14.5B acquisition in 2025Q2. The underlying business seems capable of generating strong FCF, but the quarterly path is uneven, warranting a longer-term view.

CapEx/Rev has stayed in a tight range of 3.7% to 8.2%, with the most recent quarter at 5.2%. This suggests that JNJ's capital intensity is moderate, and the majority of CapEx is likely for maintenance and routine upgrades rather than large expansion projects. The consistency of D&A around $2.0B per quarter aligns with a stable asset base, implying that growth is driven more by R&D and acquisitions than by heavy capital investment.

The extreme swings in WC Chg, particularly the -$12.7B in 2025Q4 and +$15.9B in 2025Q3, appear to be driven by timing of receivables, payables, and possibly litigation-related payments. These swings are large relative to quarterly operating cash flow, which averaged around $5.6B, indicating that working capital management is a major source of cash flow variability. Investors should focus on the cumulative effect over several quarters to assess the true cash generation capability.

Dividends have remained stable at around $3.0-3.2B per quarter, which is a significant portion of quarterly FCF, especially in weaker quarters like 2026Q1 when FCF was only $1.5B. Buybacks have been more variable, with notable repurchases in 2026Q1 ($4.0B) and 2025Q1 ($2.1B), but minimal activity in other quarters. This suggests that management is committed to the dividend but uses buybacks opportunistically, possibly to offset dilution from SBC.

The cumulative OCF of $56.1B versus cumulative net income of $51.6B shows a positive conversion over the period, despite quarterly volatility. This suggests that the accrual adjustments, including large working capital swings, tend to reverse over time, and the underlying earnings quality is sound. However, the gap is modest, and the large acquisition outflows (e.g., -$14.5B in 2025Q2) indicate that cash is being deployed for growth, which may not immediately show up in FCF.